Highlights • Survival outcomes for patients with stage IV UC and distant metastases remain poor. • Platinum-based chemotherapy remains the standard of care for untreated, advanced UC. • First-line treatment options that provide a long-term survival benefit are needed. • New data supports improved survival outcomes with immune checkpoint inhibitors.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Sohan
Contact Sohan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack